Envoy Medical, Inc. (NASDAQ:COCHW) Sees Significant Decline in Short Interest

Envoy Medical, Inc. (NASDAQ:COCHW) was the recipient of a large decline in short interest during the month of September. As of September 30th, there was short interest totaling 2,168 shares, a decline of 93.3% from the September 15th total of 32,325 shares. Based on an average trading volume of 24,603 shares, the days-to-cover ratio is presently 0.1 days.

Envoy Medical Stock Performance

Shares of NASDAQ COCHW traded up $0.00 during trading on Friday, hitting $0.04. The stock had a trading volume of 31,406 shares, compared to its average volume of 26,187. The firm has a fifty day moving average of $0.04 and a two-hundred day moving average of $0.05. Envoy Medical has a 12 month low of $0.02 and a 12 month high of $0.10.

Envoy Medical Company Profile

Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technology is designed to be implanted beneath the skin, with the goal of providing hearing support without the external components used by many conventional hearing devices.

Its lead product is the Acclaim cochlear implant, a fully implanted device that uses the body’s natural anatomy to capture sound and stimulate the cochlea. The Acclaim is intended for adults with sensorineural hearing loss and has received Breakthrough Device designation from the U.S.